Judge Upholds $25M Award in Accutane Bowel Disease Lawsuit
More Info: Defective Drugs
New Jersey judge has rejected Roche’s request for a new trial or reduction of a jury’s award of more than $25 million in damages for a man who developed severe inflammatory bowel disease from Accutane.
In an order issued last week, Judge Carol Higbee denied Roche’s request for a new trial or remittitur in a case brought by Andrew McCarrell, which was one of the first Accutane lawsuits in the United States to reach a jury.
McCarrell’s Accutane bowel disease suit was originally filed in 2003 and first went to trial in April 2007, resulting in a jury award of $2,619,000. However, following an appeal the verdict was overturned and the case was remanded for a new trial so that Roche would be permitted to introduce evidence on the total number of Accutane uses.
Following a second trial in January 2010, another New Jersey state court jury awarded McCarrell $159,540.19 to cover his medical bills and another $25 million in compensation for pain and suffering damages caused by Accutane.
You might also be interested in:
- Accutane Lawsuit Over Inflammatory Bowel Disease Results in $25M Verdict
- Acne Drug Accutane No Longer Sold
- Judge Upholds $25M Award in Accutane Bowel Disease Lawsuit
- Hagens Berman Applauds $2 Million Verdict in Accutane Lawsuit
- Settlement of Accutane Lawsuit Reached Prior to Trial
- Roche scores Accutane victory with reversal of $25M verdict
See the full, original post here: https://www.aboutlawsuits.com/award-upheld-accutane-bowel-disease-lawsuit-21151/
TriMark Legal Funding was founded in 2003 and is one of America's original lawsuit funding companies. TriMark provides pre-settlement loans and post-settlement loans to injured plaintiffs who are involved in personal injury lawsuits, employment litigation, work injury accidents and workers compensation lawsuits, mass tort litigation, and multidistrict litigation. We also provide post-settlement funding to attorneys and loans for law firms.
|Other Mass Tort Litigation Funding||Other Multidistrict Litigation Funding|
Click here to see the original article.